NDC 25021-179

Daptomycin

Daptomycin

Daptomycin is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is Daptomycin.

Product ID25021-179_12fdb998-66d0-4658-a1c0-376d974a39a2
NDC25021-179
Product TypeHuman Prescription Drug
Proprietary NameDaptomycin
Generic NameDaptomycin
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2018-01-15
Marketing CategoryNDA / NDA
Application NumberNDA208385
Labeler NameSagent Pharmaceuticals
Substance NameDAPTOMYCIN
Active Ingredient Strength350 mg/7mL
Pharm ClassesLipopeptide Antibacterial [EPC],Lipopeptides [CS]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 25021-179-15

1 VIAL in 1 CARTON (25021-179-15) > 7 mL in 1 VIAL
Marketing Start Date2018-01-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 25021-179-66 [25021017966]

Daptomycin INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA208385
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-02-01

NDC 25021-179-67 [25021017967]

Daptomycin INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA208385
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-02-01

NDC 25021-179-15 [25021017915]

Daptomycin INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA208385
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-01-15

NDC 25021-179-16 [25021017916]

Daptomycin INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA208385
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-01-15

Drug Details

Active Ingredients

IngredientStrength
DAPTOMYCIN350 mg/7mL

OpenFDA Data

SPL SET ID:548f3559-0531-4c95-9e1d-81f81a3801f1
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1996246
  • Pharmacological Class

    • Lipopeptide Antibacterial [EPC]
    • Lipopeptides [CS]

    NDC Crossover Matching brand name "Daptomycin" or generic name "Daptomycin"

    NDCBrand NameGeneric Name
    0143-9378DaptomycinDaptomycin
    0409-0106DaptomycinDAPTOMYCIN
    0409-0120DaptomycinDAPTOMYCIN
    0409-0122DaptomycinDAPTOMYCIN
    0409-2757DaptomycinDAPTOMYCIN
    0409-5933DaptomycinDaptomycin
    0703-0125DaptomycinDaptomycin
    0781-3295daptomycindaptomycin
    16714-892DaptomycinDaptomycin
    16729-434DaptomycinDaptomycin
    16729-435DAPTOMYCINDaptomycin
    25021-174daptomycindaptomycin
    25021-179DaptomycinDaptomycin
    70594-034DaptomycinDaptomycin
    70594-053DaptomycinDaptomycin
    63323-871DaptomycinDaptomycin
    63323-371DaptomycinDaptomycin
    67457-813daptomycindaptomycin
    43598-413DaptomycinDaptomycin
    68001-376DaptomycinDaptomycin
    63323-585DaptomycinDaptomycin
    71839-107daptomycindaptomycin
    57884-3151DaptomycinDaptomycin
    69097-807DaptomycinDaptomycin
    72572-102DaptomycinDaptomycin
    72572-100DaptomycinDaptomycin
    45932-0039DaptomycinDaptomycin
    71288-018DAPTOMYCINDAPTOMYCIN
    76233-091DaptomycinDaptomycin
    31722-102DaptomycinDaptomycin

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.